Axsome Therapeutics, Inc. total revenue, net income and dynamics of changes in Euro today
The dynamics of net revenue of Axsome Therapeutics, Inc. rose. The change amounted to 0 €. The dynamics of net revenue is shown in comparison with the previous report. The dynamics of net income of Axsome Therapeutics, Inc. has changed by -996 965 € in recent years. Net income, revenue and dynamics - the main financial indicators of Axsome Therapeutics, Inc.. Axsome Therapeutics, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of "net income" Axsome Therapeutics, Inc. on the graph is displayed in blue. The value of all Axsome Therapeutics, Inc. assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2017
0 €
-
-6 934 983.18 €
-
30/09/2017
0 €
-
-6 004 502.78 €
-
30/06/2017
0 €
-
-6 611 884.22 €
-
31/03/2017
0 €
-
-7 461 873.83 €
-
Show:
to
Axsome Therapeutics, Inc. financial report charts
Dates of Axsome Therapeutics, Inc. finance reports: 31/03/2017, 30/09/2017, 31/12/2017. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Axsome Therapeutics, Inc. is available online for such a date - 31/12/2017. Operating income Axsome Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Axsome Therapeutics, Inc. is -6 444 120 €
Axsome Therapeutics, Inc. quarterly report dates
Net income Axsome Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Axsome Therapeutics, Inc. is -7 430 501 € Current assets Axsome Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Axsome Therapeutics, Inc. is 35 299 541 € Total assets Axsome Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Axsome Therapeutics, Inc. is 35 555 564 €
Current cash Axsome Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Axsome Therapeutics, Inc. is 34 021 123 € Current debt Axsome Therapeutics, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Axsome Therapeutics, Inc. is 12 175 336 € Total debt Axsome Therapeutics, Inc. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Axsome Therapeutics, Inc. is 18 838 341 €
31/12/2017
30/09/2017
30/06/2017
31/03/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-6 014 380.97 €
-5 684 158.03 €
-6 300 551.53 €
-7 160 408.14 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-6 934 983.18 €
-6 004 502.78 €
-6 611 884.22 €
-7 461 873.83 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
4 194 224.62 €
3 979 657.83 €
4 673 435.12 €
5 586 082.70 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
6 014 380.97 €
5 684 158.03 €
6 300 551.53 €
7 160 408.14 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
32 945 520.51 €
30 257 519.34 €
36 247 119.91 €
43 117 894.89 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
33 184 470.10 €
30 442 907.97 €
36 439 209.73 €
43 316 510.43 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
31 752 356.37 €
29 561 180.11 €
35 460 713.18 €
42 017 403.13 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
11 363 399.37 €
7 843 204.06 €
7 663 610.37 €
7 798 530.10 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
17 582 068.55 €
14 726 797.16 €
15 202 038.27 €
15 988 657.80 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
52.98 %
48.38 %
41.72 %
36.91 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
15 602 401.55 €
15 716 110.81 €
21 237 171.46 €
27 327 852.63 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-5 871 686.74 €
-6 017 444.10 €
-6 623 345.30 €
-6 193 860.79 €
Last revenue report of Axsome Therapeutics, Inc. was 31/12/2017. According to last financial report total revenue in Axsome Therapeutics, Inc. was 0 Euro and changed by 0% since last year. Net income in Axsome Therapeutics, Inc. was -6 934 983.18 € in last quartal, net income changes to 0%.
Cash flow Axsome Therapeutics, Inc. is the net amount of cash and cash-equivalents being transferred into and out of a business. Cash flow Axsome Therapeutics, Inc. is -6 291 230 €
Axsome Therapeutics, Inc. stocks data
19X.SG stock price
Axsome Therapeutics, Inc. stock price today, 19X.SG stock quote.
